MACCHIA, Luigi
 Distribuzione geografica
Continente #
NA - Nord America 5.631
EU - Europa 1.758
AS - Asia 777
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 4
OC - Oceania 3
Totale 8.183
Nazione #
US - Stati Uniti d'America 5.625
CN - Cina 646
SE - Svezia 457
IT - Italia 435
DE - Germania 340
UA - Ucraina 146
GB - Regno Unito 123
FI - Finlandia 77
RU - Federazione Russa 76
SG - Singapore 65
FR - Francia 34
BE - Belgio 26
IN - India 26
KR - Corea 14
IE - Irlanda 13
VN - Vietnam 11
CA - Canada 5
EU - Europa 5
PL - Polonia 5
BR - Brasile 4
CH - Svizzera 4
ES - Italia 4
GR - Grecia 4
IR - Iran 4
ZA - Sudafrica 4
CZ - Repubblica Ceca 3
JP - Giappone 3
MY - Malesia 3
NL - Olanda 3
AU - Australia 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
DK - Danimarca 1
ID - Indonesia 1
IM - Isola di Man 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
PA - Panama 1
RO - Romania 1
TH - Thailandia 1
TR - Turchia 1
UG - Uganda 1
Totale 8.183
Città #
Fairfield 673
Chandler 660
Woodbridge 571
Ashburn 444
Houston 388
Jacksonville 336
Nyköping 309
Seattle 283
Cambridge 254
Wilmington 218
Ann Arbor 210
Beijing 145
Roxbury 135
Lawrence 132
Nanjing 120
New York 117
Bari 86
Des Moines 82
Boardman 77
Brooklyn 75
Dearborn 63
Inglewood 46
Singapore 42
Shenyang 39
San Diego 38
Jiaxing 36
Redwood City 33
Nanchang 32
Brussels 24
Changsha 24
Guangzhou 23
Hebei 21
Paris 20
Los Angeles 19
Tianjin 18
Pune 16
Jinan 15
Princeton 14
Wuhan 14
Dublin 13
Milan 12
Rome 11
Dong Ket 10
Shanghai 10
Valenzano 10
Modugno 9
Washington 9
Corato 7
Cutrofiano 7
Hefei 7
Zhengzhou 7
Kunming 6
London 6
San Francisco 6
Bitonto 5
Hangzhou 5
Helsinki 5
Martina Franca 5
Shenzhen 5
Taranto 5
Bolzano 4
Forlì 4
Genoa 4
Munich 4
Ningbo 4
Norwalk 4
Salerno 4
West Jordan 4
Amsterdam 3
Athens 3
Auburn Hills 3
Barcelona 3
Chengdu 3
Edinburgh 3
Falls Church 3
Foggia 3
Fuzhou 3
Heze 3
Indianapolis 3
Jinhua 3
Melendugno 3
Montefiore Conca 3
Mumbai 3
Nardò 3
Nuremberg 3
Nürnberg 3
Polignano a Mare 3
Quanzhou 3
Rochester 3
Sannicandro di Bari 3
Taizhou 3
Torino 3
Toronto 3
Triggiano 3
Turi 3
Yiwu 3
Acquaviva delle Fonti 2
Altamura 2
Ardabil 2
Bergamo 2
Totale 6.136
Nome #
Maintenance-Phase Subcutaneous Immunotherapy with House Dust Mites Induces Cyclic Immunologic Effects 155
Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study 152
Reazioni ritardate a farmaci: dal test di proliferazione linfocitaria alla desensibilizzazione. 140
Hymenoptera Venom Allergy: Management of children and adults in clinical practice 127
Il fenetil estere dell'acido caffeico è un potente inibitore della via metabolica 5-lipossigenasica -leucotrienica 117
A 13-year real-life study on efficacy, safety and biological effects of Vespula venom immunotherapy 107
KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection 106
Efficacy of allergen immunotherapy in reducing the likelihood of developing new allergen sensitizations: a systematic review 103
Pollini e pollinosi in Puglia. La notte dei Ricercatori. Bari, 23 settembre 2011 102
Indirect food contact in severe fish allergy 101
null 101
5-lipoxygenase upregulation by dexamethasone in human mast cells 96
Allergy to artichoke: a case report 96
Monitoring of atmospheric conditions and forecast of olive pollen season. 86
Arachidonic acid metabolism in the human mast cell line HMC-1. 5-lipoxygenase gene expression and biosynthesis of thromboxane 85
Beauvericin: chemistry, biology and significance 84
Wasp immunotherapy induced long-term and IgG4-independent protection 84
Is immunotherapy with fungal vaccines effective? 84
Fig and mulberry cross-allergy 83
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 83
Purification and fine characterization of the major allergen from Olea europaea pollen extract 80
Test di proliferazione linfocitaria nella diagnosi delle reazioni ritardate a farmaci 80
Novel inhibitory effect on 5-lipoxygenase activity by the anti-asthma drug montelukast 79
Allergy to pomegranate and artichoke, novel food allergens of the Mediterranean Diet 79
Allergeni alimentari emergenti della Dieta Mediterranea. 78
Should succinate esters be considered excipients in systemic corticosteroid allergy? 78
Safety and treatment compliance of subcutaneous immunotherapy: A 30-year retrospective study 77
null 74
Cost-effectiveness of grass pollen allergen immunotherapy in adults 74
null 74
Second generation antihistamines in the treatment of seasonal allergic rhinitis due to Parietaria and cypress pollen 73
A HPTLC approach to quantitative determination of some prostaglandins in serum: study in normal and asthmatic subjects 73
L'allergia alimentare della Dieta Mediterranea 73
Sviluppo ed applicazione di un protocollo di desensibilizzazione rapida per Rituximab. 72
null 72
null 71
null 70
Expression of prostaglandin endoperoxide H synthase 1 and 2 in human placenta at term 68
Studi su Omalizumab nella terapia dell'asma severo. Valutazione degli effetti sulla risposta immunologica IgE in vivo. Valutazione della tollerabilità. 68
null 68
null 68
La Notte dei Ricercatori - 23 settembre 2011 - Piazza del Ferrarese - Bari 67
Allergia al latte. Studio sulla risposta IgE-mediata in vivo verso frazioni proteiche di latte di capra Garganica 67
Vicia faba hypersensitivity and ASA intolerance in a farmer: A case report 66
Omalizumab in long-term treatment of refractory chronic spontaneus urticaria:effects of discontinuation 66
Cytotoxic effects of the mycotoxin beauvericin to human cell lines of myeloid origin 65
null 65
null 65
null 64
null 64
Italian real-life experience of omalizumab 63
Metodo diagnostico ELISA applicabile all'allergia respiratoria da polline di Cupressus arizonica 63
Zucchini allergy: a case report 62
Retrospective monitoring in the management of persistent asthma 62
General adverse reaction to aspirin administered by transdermal iontophoresis 60
Terapia dell'asma severo con omalizumab: uno studio real life in 51 pazienti. 60
null 60
Desensitization in Iron Product Allergy 60
A new subcutaneous protocol for persistent desensitization to Rituximab 58
null 58
Idiopathic nonhistaminergic angioedema: A single-center real-life experience from Italy 58
Allergia alimentare a Leguminose della dieta mediterranea: Phaseoulus vulgaris (fagiolo) e Pisum Sativum (pisello) 57
Allergens of Arizona cypress (Cupressus arizonica) pollen: characterization of the pollen extract and identification of the allergenic components 57
Association between γ marker, human leucocyte antigens and killer immunoglobulin-like receptors and the natural course of human cytomegalovirus infection: a pilot study performed in a Sicilian population 57
null 57
Allergy to mint (Mentha spicata) 55
Omalizumab nel trattamento dell'allergia alimentare 55
Cyclooxygenase-2 expression in oral squamous cell carcinoma 54
null 54
Omalizumab in severe allergic asthma: efficacy assessment by comparison of symptom score and peak expiratory flow values before and after therapy 53
Beauvericin cytotoxicity to the invertebrate cell line SF-9 53
Olive pollen allergy in Bari, Italy 53
Long-term treatment of refractory severe chronic urticaria by omalizumab: analysis of two cases 52
Leukotriene biosynthesis inhibition and direct 5-lipoxygenase (5-LO) non competitive inhibition by the Cys-LT1 receptor antagonists montelukast 52
Omalizumab For The Treatment of Persistent Drug Induced Urticaria Elicited By Thienopyridines: A Case Report 52
Biosensori cellulari nella valutazione di nuovi detergenti ecosostenibili 51
Immunological and non-immunological mechanisms of allergic diseases in the elderly: Biological and clinical characteristics 51
null 50
Rapid desensitization to Rituximab 49
Novel inhibitory effect on 5-lipoxygenase by the anti-asthma drug montelukast 49
Due anni di terapia con Omalizumab: valutazione di efficacia e tollerabilità in 10 pazienti con asma severo non controllato 48
Apoptosis induced by the Fusarium mycotoxin beauvericin in mammalian cells 48
null 48
Immunological characterization of onion (Allium cepa) allergy 48
High levels of gut-homing immunoglobulin A-positive+B lymphocytes support the pathogenic role of intestinal mucosal hyperresponsiveness in immunoglobulin A nephropathy patients 48
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 45
Airborne Cupressaceae pollen in Southern Italy 44
Inibizione della via metabolica 5-lipossigenasica/leucotrienica da parte di sostanze antiossidanti di origine naturale. 44
Planned omalizumab discontinuation in CSU management as a sustainable strategy: A 2-year real-life study 44
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 44
High levels of gut-homing immunoglobulin A+ B lymphocytes support the pathogenic role of intestinal mucosal hyperresponsiveness in immunoglobulin A nephropathy patients 44
L'orticaria (da un punto di vista allergologico) 43
Fennel (Foeniculum vulgare) allergy. 43
IgE-mediated reaction induced by arugula (Eruca sativa) ingestion compared with a spectrum of Brassicaeae proteins 42
Omalizumab nell'orticaria cronica spontanea: uno studio real-life su 14 pazienti 42
Benralizumab improves patient reported outcomes and functional parameters in difficult-to-treat patients with severe asthma: Data from a real-life cohort 42
Studio del pH e dei markers di stress ossidativi nel condensato di pazienti con fibrosi cistica. 41
Multicenter double-blind comparative study of terfenadine and cetirizine in hay fever 41
Toxicity assessment of fungal biocontrol agents using two different (Artemia salina and Daphnia magna) invertebrate bioassays 41
Studio dell'inquinamento atmosferico nell' area urbana di Bari per l' anno 1981 40
Totale 6.785
Categoria #
all - tutte 34.861
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.861


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.667 0 90 82 167 162 175 205 149 193 139 232 73
2020/20211.236 118 99 107 72 144 105 122 103 101 136 70 59
2021/20221.089 30 100 42 41 67 120 25 67 52 78 181 286
2022/20231.587 186 250 122 118 176 203 26 151 282 6 40 27
2023/2024788 58 114 35 39 47 237 44 43 27 32 23 89
2024/2025224 194 30 0 0 0 0 0 0 0 0 0 0
Totale 8.442